Cardiovascular disease in critically ill COVID-19 patients.

18 March 2022 (19:35 - 19:40)

Organised by:

About the speaker

Doctor Vanessa Lopes

Centro Hospitalar E Universitario De Coimbra, Coimbra (Portugal)

4 More presentations in this session

Presentation thumbnail

Outcomes in patients with acute heart failure treated with levosimendan: the impact of right ventricular function.

Doctor K. Tapia (Buenos Aires, AR)

Presentation thumbnail

Safety and effectiveness of angiotensin receptor-neprilysin inhibitors in patients with heart failure with preserved ejection fraction (ARNI-PRESERVED study).

Doctor P. Jariwala (Hyderabad, IN)

Presentation thumbnail

Time is kidney: relation between pain-to-balloon time and acute kidney injury among ST segment elevation myocardial infarction patients undergoing primary percutaneous intervention.

Doctor D. Zahler (Tel Aviv, IL)

Presentation thumbnail

Application of artificial intelligence to optimize the diagnosis and treatment of acute coronary syndrome: a real experience.

Doctor D. Mota (Sao Paulo, BR)

Access the full session

Session thumbnail

Best ePoster in Insights on classical and new aspects of acute care

The Event

Event poster

ESC Acute CardioVascular Care 2022

18 March 2022 19:35 CET

You may be interested in

Congress Presentation

Cardiac complications and outcomes in critically ill COVID-19 patients: a prospective multi-center cohort study

20 May 2023

Webinar

Cardiovascular involvement in COVID-19 patients: multimodality imaging for diagnosis, risk stratification and management

10 June 2021

Congress Session

The best acute cardiovascular-care science

31 August 2024

Congress Presentation

Endothelial dysfunction in the post-COVID-19 period: a meta-analysis

29 August 2022

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources